US2016177343A1PendingUtilityA1
Polypeptides Having Glucoamylase Activity and Polynucleotides Encoding Same
Est. expiryNov 8, 2030(~4.3 yrs left)· nominal 20-yr term from priority
C12P 7/14C12N 9/2417C12P 2203/00C12Y 302/01133C12N 9/242C12N 9/2428C12Y 302/01001C12Y 302/01003C07K 2319/20C12N 15/8245A23L 33/18Y02E50/10C12P 7/10A23L 29/06A23L 29/35
52
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention relates to isolated polypeptides having glucoamylase activity and isolated polynucleotides encoding the polypeptides. The invention also relates to nucleic acid constructs, vectors, and host cells comprising the polynucleotides as well as methods of producing and using the polypeptides.
Claims
exact text as granted — not AI-modified1 . An isolated polypeptide having glucoamylase activity, selected from the group consisting of:
(a) a polypeptide comprising an amino acid sequence having preferably at least 72%, more preferably at least 73%, more preferably at least 74%, more preferably at least 75%, more preferably at least 76%, more preferably at least 77%, more preferably at least 78%, more preferably at least 79%, more preferably at least 80%, more preferably at least 81%, more preferably at least 82%, more preferably at least 83%, more preferably at least 84%, more preferably at least 85%, more preferably at least 86%, more preferably at least 87%, more preferably at least 88%, more preferably at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to the mature polypeptide of SEQ ID NO: 2; (b) a polypeptide comprising an amino acid sequence having preferably at least 72%, more preferably at least 73%, more preferably at least 74%, more preferably at least 75%, more preferably at least 76%, more preferably at least 77%, more preferably at least 78%, more preferably at least 79%, more preferably at least 80%, more preferably at least 81%, more preferably at least 82%, more preferably at least 83%, more preferably at least 84%, more preferably at least 85%, more preferably at least 86%, more preferably at least 87%, more preferably at least 88%, more preferably at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to the catalytic domain shown as amino acids 21 to 472 of SEQ ID NO: 2; (c) a polypeptide encoded by a polynucleotide that hybridizes under preferably at least medium-high stringency conditions, and most preferably at least high stringency conditions with (i) the mature polypeptide coding sequence of SEQ ID NO: 1, (ii) the cDNA sequence contained in SEQ ID NO: 1, or (iii) a full-length complementary strand of (i) or (ii); (d) a polypeptide encoded by a polynucleotide comprising a nucleotide sequence having preferably at least 72%, more preferably at least 73%, more preferably at least 74%, more preferably at least 75%, more preferably at least 76%, more preferably at least 77%, more preferably at least 78%, more preferably at least 79%, more preferably at least 80%, more preferably at least 81%, more preferably at least 82%, more preferably at least 83%, more preferably at least 84%, more preferably at least 85%, more preferably at least 86%, more preferably at least 87%, more preferably at least 88%, more preferably at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to the mature polypeptide coding sequence of SEQ ID NO: 1; and (e) a variant comprising a substitution, deletion, and/or insertion of one or more (several) amino acids of the mature polypeptide of SEQ ID NO: 2.
2 . The polypeptide of claim 1 , which is encoded by a polynucleotide comprising or consisting of the nucleotide sequence of SEQ ID NO: 1; or a subsequence thereof encoding a fragment having glucoamylase activity.
3 . The polypeptide of claim 1 , wherein the mature polypeptide is amino acids 20 to 573 of SEQ ID NO: 2.
4 . An isolated polypeptide having carbohydrate-binding activity, comprising a carbohydrate binding module having at least 80%, more preferably at least 81%, more preferably at least 82%, more preferably at least 83%, more preferably at least 84%, more preferably at least 85%, more preferably at least 86%, more preferably at least 87%, more preferably at least 88%, more preferably at least 89%, more preferably at least 90%, more preferably at least 91%, more preferably at least 92%, even more preferably at least 93%, most preferably at least 94%, and even most preferably at least 95%, such as at least 95%, at least 97%, at least 98%, at least 99% or even 100% identity to the carbohydrate-binding domain shown as amino acids 480 to 573 of SEQ ID NO: 2.
5 . A hybrid enzyme which comprises a catalytic domain and a carbohydrate-binding domain of claim 4 .
6 . The hybrid enzyme of claim 5 , wherein the catalytic domain has an enzyme activity selected from the group consisting of alpha-amylase, amylopullulanase, beta-amylase, CGTase, glucoamylase, isoamylase, maltogenic amylase, and pullulanase.
7 . An isolated polynucleotide comprising a nucleotide sequence that encodes the polypeptide of claim 1 .
8 . A nucleic acid construct comprising the polynucleotide of claim 7 operably linked to one or more (several) control sequences that direct the production of the polypeptide in an expression host.
9 . A recombinant expression vector comprising the nucleic acid construct of claim 8 .
10 . A recombinant host cell comprising the nucleic acid construct of claim 8 .
11 . A method of producing the polypeptide of claim 1 , comprising: (a) cultivating a host cell comprising a nucleic acid construct comprising a nucleotide sequence encoding the polypeptide under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide.
12 . A method of producing the polypeptide of claim 1 , comprising: (a) cultivating a transgenic plant or a plant cell comprising a polynucleotide encoding the polypeptide under conditions conducive for production of the polypeptide; and (b) recovering the polypeptide.
13 . A transgenic plant, plant part or plant cell transformed with a polynucleotide encoding the polypeptide of claim 1 .
14 . A composition comprising an alpha-amylase and a polypeptide of claim 1 .
15 . A process of producing a fermentation product from starch-containing material comprising the steps of:
(a) liquefying starch-containing material; (b) saccharifying the liquefied material; and (c) fermenting with a fermenting organism;
wherein step (b) is carried out using at least a glucoamylase according to claim 1 .
16 . A process of producing a fermentation product from starch-containing material, comprising the steps of:
(a) saccharifying starch-containing material at a temperature below the initial gelatinization temperature of said starch-containing material; and (b) fermenting with a fermenting organism,
wherein step (a) is carried out using at least a glucoamylase according to claim 1 .Join the waitlist — get patent alerts
Track US2016177343A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.